Filing Details
- Accession Number:
- 0000882104-20-000211
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-17 16:49:14
- Reporting Period:
- 2020-12-16
- Accepted Time:
- 2020-12-17 16:49:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882104 | Pdl Biopharma Inc. | PDLI | Biological Products, (No Disgnostic Substances) (2836) | 943023969 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1453373 | Lewis Christopher Stone | C/O Pdl Biopharma, Inc. 932 Southwood Blvd. Incline Village NV 89451 | Vp, Gen. Counsel & Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-12-16 | 200,000 | $2.56 | 405,559 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
